Efficacy of TXI (Texture and Color Enhancement Imaging) Observation in Lower Gastrointestinal Endoscopy

Efficacy of TXI (Texture and Color Enhancement Imaging) Observation in Lower Gastrointestinal Endoscopy - TXI study in lower gastrointestinal endoscopy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043190

Enrollment

100

Registered

2021-01-31

Start date

2021-01-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal tumor, inflammatory bowel disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing lower gastrointestinal endoscopy at our hospital who can give consent

Exclusion criteria

Exclusion criteria: Patients for whom consent could not be obtained or for whom appropriate images could not be obtained.

Design outcomes

Primary

Measure	Time frame
For patients scheduled for lower gastrointestinal endoscopy (including extended endoscopy for colorectal tumors and endoscopic treatment for colorectal tumors) at our hospital, imaging with WLI, TXI and indigocarmine spraying with normal observation for about 10-20 minutes or diagnosis before treatment (qualitative diagnosis: tumor or non-tumor, boundary Diagnosis: ease of determining the border between tumor and non-tumor areas, inflammatory findings and vascular permeability in case of inflammatory lesions). If endoscopic treatment is to be performed afterwards, the post-treatment pathology results and the preoperative endoscopic diagnosis should be compared at a later date to determine the accuracy of the preoperative diagnosis.	—

Measure

Time frame

For patients scheduled for lower gastrointestinal endoscopy (including extended endoscopy for colorectal tumors and endoscopic treatment for colorectal tumors) at our hospital, imaging with WLI, TXI and indigocarmine spraying with normal observation for about 10-20 minutes or diagnosis before treatment (qualitative diagnosis: tumor or non-tumor, boundary Diagnosis: ease of determining the border between tumor and non-tumor areas, inflammatory findings and vascular permeability in case of inflammatory lesions). If endoscopic treatment is to be performed afterwards, the post-treatment pathology results and the preoperative endoscopic diagnosis should be compared at a later date to determine the accuracy of the preoperative diagnosis.

—

Countries

Japan

Contacts

Public ContactTsubasa Ishikawa

Chiba University Hospital Gastroenterology

ishikawa.tsubasa@chiba-u.jp0432262083

Outcome results